This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Diffuse gastric cancer: Histologic, molecular, and genetic basis of disease
Translational Gastroenterology and Hepatology. 2020 Oct;5 :52
PMID: 33073047 PMCID: PMC7530323 URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085189941&doi=10.21037%2ftgh.2020.01.02&partnerID=40&md5=feb3dc49e07f9f6a6a3ec9f81b9bcfbd
AbstractDiffuse gastric cancer (DGC) is a distinct histopathologic and molecular disease, characterized by mutations in CDH1, RHOA, and others. In addition, DGC is associated with familial syndromes, including hereditary DGC and germline mutation in CDH1. Clinically, this subtype of gastric adenocarcinoma is associated with a poor prognosis and possible resistance to available systemic therapies. An understanding of the genetic and molecular underpinnings of DGC may help inform of its clinical behavior and aid in screening, diagnosis, and response to treatment. In this review, we will review the current histologic, molecular, and genetic landscape of DGC and its relevance to clinical practice.
NotesExport Date: 1 June 2020